i think it might be worth caring.
If you can believe the accounts it would seem to me that the company has paid $16.348M 19/5/12 as at 30 June. I think all the sequel tranches have been deferred.
a basic valuation IMO is to asign a probability of litigation success less legals times prize. Guess $2m legals then anything above a 15% probability of success is money in the bank on this basis. DYOR.
in a perfect world the fight will be fought but more inmportantly Kangwane project will be progressed with gusto and the vendors will be moribound in legal proceedings. I suspect the 'white knight' shareholder will be sufficiently motivated with the end prize. IMO equally he cannot go it alone ... so long as rights to Mblia or associated actions are and remain with ZYL. It will be in his interest to fund some progress... both Kangwane as evidence of litigation strength in the eyes of the vendor and the litigation itself. In fact IMO its possible that he/she might just wear the vendors down. Of course all the above assumes the investor has deep pockets...
this will be a high risk bumpy ride and no doubt the white knights of this world will want there share of spoils...but if the risk profile fits, the returns might sit very comfortably in one speculators pocket...
good luck
- Forums
- ASX - By Stock
- HWK
- Ann: Mbila Further Update
Ann: Mbila Further Update , page-42
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HWK (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online